Randomized controlled study of the T-type calcium channel antagonist MK-8998 for the treatment of acute psychosis in patients with schizophrenia-Reference-Cited by-同舟云学术

Randomized controlled study of the T-type calcium channel antagonist MK-8998 for the treatment of acute psychosis in patients with schizophrenia

Published:2013-03 Issue:2 Volume:28 Page:124-133
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Hum. Psychopharmacol Clin Exp

Author:

Egan Michael F.¹,Zhao Xin¹,Smith Andrew¹,Troyer Matthew D.¹,Uebele Victor N.¹,Pidkorytov Valerii²,Cox Kevin³,Murphy Michael⁴,Snavely Duane¹,Lines Christopher¹,Michelson David¹

Affiliation:

1. Merck Sharp & Dohme Corp.; Whitehouse, Station; NJ; USA

2. Institute of Neurology, Psychiatry and Narcology AMS; Kharkiv; Ukraine

3. Worldwide Clinical Trials; Ojai; CA; USA

4. Worldwide Clinical Trials; King of Prussia; PA; USA

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology,Neurology

Reference31 articles.

1. A rating scale for drug-induced akathisia;Barnes;Br J Psychiatry,1989

2. The Barnes Akathisia Rating Scale-revisited;Barnes;J Psychopharmacol,2003

3. Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial;Beasley;Psychopharmacology (Berl),1996a

4. Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial;Beasley;Neuropsychopharmacology,1996b

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential Outcomes of Placebo Treatment Across 9 Psychiatric Disorders;JAMA Psychiatry;2024-08-01

2. Peak alpha frequency and electroencephalographic microstates are correlated with aggression in schizophrenia;Journal of Psychiatric Research;2024-07

3. Discovery of α‐Obscurine Derivatives as Novel Ca_v3.1 Calcium Channel Blockers;Chemistry & Biodiversity;2024-02-22

4. Back to the Future of Neuropsychopharmacology;Advances in Neurobiology;2023

5. Onset of Action of Selected Second-Generation Antipsychotics (Pines)–A Systematic Review and Meta-Analyses;Biomedicines;2022-12-29